Evidence map›Paper›PMID 35304495›Full record

ArticleScientific reports2022

Optimization of an O

Anne Mouré, Sawsen Bekir, Elodie Bacou, Quentin Pruvost, Karine Haurogné, Marie Allard, Laurence De Beaurepaire, Steffi Bosch, David Riochet, Olivier Gauthier and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Anne Mouré *Oniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Sawsen Bekir *Oniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Elodie BacouOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Quentin PruvostOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Karine HaurognéOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Marie AllardOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Laurence De BeaurepaireOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Steffi BoschOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
David RiochetSSR Pédiatriques ESEAN-APF France Handicap, Nantes University Hospital, Nantes, France.
Olivier GauthierOniris, Nantes Université, INSERM, RMeS, UMR 1229, F-44000, Nantes, France.
Gilles BlanchoCRTI, UMR 1064, INSERM, Nantes Université, 44000, Nantes, France.
Jean-Paul SoulillouCRTI, UMR 1064, INSERM, Nantes Université, 44000, Nantes, France.
Denis PonceletGEPEA, UMR CNRS 6144 FR, Nantes Université, 44000, Nantes, France.
Grégoire MignotOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Philippe CourcouxOniris, INRAE, StatSC, USC 1381, 44000, Nantes, France.
Dominique JegouOniris, INRAE, IECM, USC 1383, 44300, Nantes, France.
Jean-Marie BachOniris, INRAE, IECM, USC 1383, 44300, Nantes, France. jean-marie.bach@oniris-nantes.fr.
Mathilde MosserOniris, INRAE, IECM, USC 1383, 44300, Nantes, France. mathilde.mosser@oniris-nantes.fr.
Bipar · FRCentre Hospitalier Universitaire de Nantes · FRLaboratoire de Génie des Procédés – Environnement – Agro-alimentaire · FRNantes Université · FRSkeleton Technologies (Estonia) · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A bioartificial pancreas (BAP) encapsulating high pancreatic islets concentration is a promising alternative for type 1 diabetes therapy. However, the main limitation of this approach is O

Indexed as

Diabetes Mellitus, Type 1Islets of LangerhansIslets of Langerhans TransplantationPancreas, ArtificialHumansHypoxiaPancreas

Identifiers

PMID35304495
PMCPMC8933496
OpenAlexW4226203010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.